Skip to main content
Log in

Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: Selective depression of cell responses mediated by complement-derived chemoattractants

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Rat neutrophil chemotactic responses to N-formyl-methionyl-leucyl-phenylalanine (FMLP), leukotriene (LT) B4, and lipopolysaccharide-activated serum (LPS-AS) were quantitatively assessed using the micropore filter system. Cells were suspended in either normal or diabetic rat serum for testing. Diabetic donor serum did not affect migration of neutrophils in a concentration gradient of the synthetic chemotactic agents. In contrast, the migratory responses to LPS-AS were significantly less than normal in this circumstance. Summation of effects was observed when FMLP and LPS-AS, or LTB4 and LPS-AS were simultaneously added to the test chamber, with cells suspended in normal serum. Suspended in diabetic rat serum neutrophils responded normally to the synthetic chemoattractants but the response to the activated serum was blocked. Cells previously incubated in the presence of diabetic donor serum then transferred to a culture medium for testing, presented reduced migratory responses to LPS-AS. Supramaximal, inhibitory concentrations of FMLP and LTB4, did not influence the response of neutrophils to LPS-AS.In vivo, suppression of cellular emigration to an inflamed area was observed from the early stages of the diabetic state. The inhibitory activity of chemotaxis in diabetes mellitus was previously reported to be associated with a protein factor in plasma of the animals. It is suggested that the inhibitory factor of chemotaxis in diabetes mellitus interacts with neutrophil receptors for complement-derived chemoattractants to induce blockade of cell-oriented locomotion eitherin vitro orin vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. A. Savin,Bacterial infections in diabetes mellitus. Br. J. Dermatol.91, 481–487 (1974).

    PubMed  Google Scholar 

  2. J. G. Larkin, B. M. Frier and J. Ireland.Diabetes mellitus and infection. Postgrad. Med. J.61, 233–237 (1985).

    PubMed  Google Scholar 

  3. J. Garcia-Leme,Hormones and Inflammation, 238 pp, CRC Press, Boca Raton 1989.

    Google Scholar 

  4. J. Garcia-Leme, L. Hamamura, R. H. Migliorini and M. P. Leite,Influence of diabetes upon the inflammatory response of the rat: a pharmacological analysis. Eur. J. Pharmacol.23, 74–81 (1973).

    Article  PubMed  Google Scholar 

  5. J. Garcia-Leme, G. M. Bohm, R. H. Migliorini and M. Z. A. Souza,Possible participation of insulin in the control of vascular permeability. Eur. J. Pharmacol.29, 298–306 (1974).

    Article  PubMed  Google Scholar 

  6. M. A. S. Llorach, G. M. Bohm and J. Garcia-Leme,Decreased vascular reactions to permeability factors in experimental diabetes. Br. J. Exp. Pathol.57, 747–754 (1976).

    PubMed  Google Scholar 

  7. B. M. Altura, S. Halevy and P. D. M. V. Turlapaty,Vascular smooth muscle in diabetes and its influence on the reactivity of blood vessels. Adv. Microcircul.8, 118–150 (1979).

    Google Scholar 

  8. Z. B. Fortes, J. Garcia-Leme and R. Scivoletto,Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br. J. Pharmacol.78, 39–48 (1983).

    PubMed  Google Scholar 

  9. Z. B. Fortes, J. Garcia-Leme and R. Scivoletto,Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br. J. Pharmacol.79, 771–781 (1983).

    PubMed  Google Scholar 

  10. Z. B. Fortes, J. Garcia-Leme and R. Scivoletto,Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell. Br. J. Pharmacol.83, 635–643 (1984).

    PubMed  Google Scholar 

  11. A. G. Mowat and J. Baum,Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N. Engl. J. Med.284, 621–624 (1971).

    PubMed  Google Scholar 

  12. M. E. Miller and L. Baker,Leukocyte functions in juvenile diabetes mellitus: humoral and cellular aspects. J. Pediatr.81, 979–982 (1972).

    PubMed  Google Scholar 

  13. H. R. Hill, H. S. Sauls, J. L. Dettloff and P. G. Quie,Impaired leukocyte responsiveness in patients with juvenile diabetes mellitus. Clin. Immunol. Immunopathol.2, 395–403 (1974).

    Article  PubMed  Google Scholar 

  14. A. E. Mohandes, J. L. Touraine, M. Osman and B. Salle,Neutrophil chemotaxis in infants of diabetic mothers and in preterms at birth. J. Clin. Lab. Immunol.8, 117–120 (1982).

    PubMed  Google Scholar 

  15. M. A. A. Pereira, P. Sannomiya and J. Garcia-Leme,Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes36, 1307–1314 (1987).

    PubMed  Google Scholar 

  16. S. Boyden,The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med.15, 453–466 (1962).

    Article  Google Scholar 

  17. S. H. Zigmond and J. G. Hirsch,Leukocyte locomotion and chemotaxis: new method for evaluation and demonstration of cell-derived chemotactic factor. J. Exp. Med.137, 387–410 (1973).

    Article  PubMed  Google Scholar 

  18. W. G. Spector,The mediation of altered capillary permeability in acute inflammation. J. Pathol. Bacteriol.72, 367–380 (1956).

    Article  Google Scholar 

  19. B. Desbuquois and G. D. Aurbach,Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol.33, 732–738 (1971).

    Google Scholar 

  20. P. Sannomiya, H. J. Anteghini, E. S. O. Vianna and J. Garcia-Leme,Involvement of lymphocytes in non-immune inflammation: dual effect of glucocorticoids. Agents and Actions16, 552–557 (1985).

    PubMed  Google Scholar 

  21. H. V. Showell, R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswanikumar, B. Corcoran and E. L. Becker,The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal ensyme secretion for neutrophils. J. Exp. Med.143, 1154–1169 (1976).

    Google Scholar 

  22. E. J. Goetzl and W. C. Pickett,Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J. Exp. Med.153, 482–487 (1981).

    Article  PubMed  Google Scholar 

  23. C. L. Malmsten, J. Palmblad, A. M. Udén, O. Radmark, L. Engstedt and B. Samuelsson,Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes. Acta Physiol. Scand.110, 449–451 (1980).

    PubMed  Google Scholar 

  24. M. J. H. Smith, A. W. Ford-Hutchinson and M. A. Bray,Leukotriene B: a potential mediator of inflammation. J. Pharm. Pharmacol.32, 517–518 (1980).

    PubMed  Google Scholar 

  25. H. S. Shin, R. Snyderman, E. Friedman, A. Mellors and M. M. Mayer,A chemotactic and anaphylatoxic fragment cleaved from guinea pig C′5 by EAC′ 1a, 4, 2a, 3. Science162, 361–363 (1968).

    PubMed  Google Scholar 

  26. J. A. Jensen, R. Snyderman and S. E. Mergenhagen,Chemotactic activity, a property of guinea pig C′5-anaphylatoxin. InCellular and Humoral Mechanisms of Anaphylaxis and Allergy. (Ed. H. Z. Movat) pp. 265–278, Karger, Basel 1969.

    Google Scholar 

  27. P. A. Ward,The heterogeneity of chemotactic factors for neutrophils generated from the complement system. InCellular and Humoral Mechanisms in Anaphylaxis and Allergy. (Ed. H. Z. Movat) pp. 279–288, Karger, Basel 1969.

    Google Scholar 

  28. P. A. Ward and L. J. Newman,A neutrophil chemotactic factor from human C′5. J. Immunol.102, 93–99 (1969).

    PubMed  Google Scholar 

  29. L. Pillemer, M. D. Shoenberg, L. Blum and L. Wurz,Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science122, 545–549 (1955).

    PubMed  Google Scholar 

  30. L. H. Muschel, K. Schmoker and P. M. Webb,Anti-complementary actions of endotoxin. Proc. Soc. Exp. Biol. Med.117, 639–643 (1964).

    PubMed  Google Scholar 

  31. O. Gotze and H. J. Muller-Eberhard,The C3 activator system: an alternate pathway of complement activation. J. Exp. Med. Suppl., vol134, 90–180 (1971).

    Google Scholar 

  32. R. Snyderman and M. C. Pike,Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption. Infect. Immun.11, 273–279 (1975).

    PubMed  Google Scholar 

  33. D. C. Morrison and L. F. Kline,Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J. Immunol.118, 362–368 (1977).

    PubMed  Google Scholar 

  34. R. Snyderman, H. S. Shin, J. K. Phillips, H. Gewurz and S. E. Mergenhagen,A neutrophil chemotactic factor derived from C′5 upon interaction of guinea-pig serum with endotoxin. J. Immunol.103, 413–422 (1969).

    PubMed  Google Scholar 

  35. S. Aswanikumar, B. Corcoran, E. Schiffmann, A. R. Day, R. J. Freer, H. J. Showell and E. L. Becker,Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem. Biophys. Res. Commun.74, 810–822 (1977).

    Article  PubMed  Google Scholar 

  36. L. T. Williams, R. Snyderman, M. C. Pike and R. J. Lefkowitz,Specific receptor site for chemotactic peptides on human polymorphonuclear leukocytes. Proc. Nat. Acad. Sci. USA74, 1204–1208 (1977).

    PubMed  Google Scholar 

  37. S. J. Sullivan and S. H. Zigmond,Chemotactic peptide modulation in polymorphonuclear leukocytes. J. Cell. Biol.85, 703–711 (1980).

    Article  PubMed  Google Scholar 

  38. W. A. Marasco, J. C. Fantone, R. J. Freer and P. A. Ward,Characterization of the rat neutrophil formyl peptide chemotaxis receptor. Am J. Pathol.111, 273–281 (1983).

    PubMed  Google Scholar 

  39. D. W. Goldman and G. J. Goetzl,Specific binding of leukotriene B4 to receptors of human polymorphonuclear leukocytes. J. Immunol.129, 1600–1604 (1982).

    PubMed  Google Scholar 

  40. R. A. Kreisle and C. W. Parker,Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes. J. Exp. Med.157, 628–641 (1983).

    Article  PubMed  Google Scholar 

  41. D. E. Chenoweth and T. E. Hugli,Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol.17, 151–161 (1980).

    Article  PubMed  Google Scholar 

  42. G. D. Warden, A. D. Mason, Jr. and B. A. Pruitt, Jr.,Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the manegement of thermal injuries. Ann. Surg.181, 363–369 (1975).

    PubMed  Google Scholar 

  43. J. B. Grogan,Suppressed in vitro chemotaxis of burn neutrophils. J. Trauma16, 985–988 (1976).

    PubMed  Google Scholar 

  44. S. M. Fikrig, S. C. Karl and L. Suntharalingam,Neutrophil chemotaxis in patients with burns. Ann. Surg.186, 746–748 (1977).

    PubMed  Google Scholar 

  45. J. M. Davis, P. Dineen and J. I. Gallin,Neutrophil degranulation and abnormal chemotaxis after thermal injury. J. Immunol.124, 1467–1471 (1980).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sannomiya, P., Pereira, M.A.A. & Garcia-Leme, J. Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: Selective depression of cell responses mediated by complement-derived chemoattractants. Agents and Actions 30, 369–376 (1990). https://doi.org/10.1007/BF01966301

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966301

Keywords

Navigation